Practice Management

Top Story

Gottlieb sees ‘watershed opportunity’ to shape future of FDA’s regulatory process

Gottlieb sees ‘watershed opportunity’ to shape future of FDA’s regulatory process
November 16, 2017

WASHINGTON — When diagnosed with Hodgkin lymphoma at the age of 33 years, FDA Commissioner Scott Gottlieb, MD, was told he had a 90% chance of survival.

“Ninety percent doesn’t sound so good if it’s you,” Gottlieb, now 44, told HemOnc Today following a keynote presentation at the Friends of Cancer Research Annual Meeting. “So, to me, that 10% sounded pretty grim.”

Meeting News

AMA adopts new strategy for genetic tests, therapeutics

November 15, 2017
AMA recently voted to advance the development of a comprehensive strategy that allows more consistent coverage of genomic and genetic tests and precision medicine, a…

Trump nominates former pharmaceutical executive for HHS secretary

November 13, 2017
President Donald J. Trump has nominated Alex Azar II, the head of pharmaceutical company Eli Lilly’s U.S.-based operations until this past January, to be his next…
In the Journals

Burnout, dissatisfaction drive 1 in 5 physicians to plan on reducing work hours

November 10, 2017
Survey results published in Mayo Clinic Proceedings reveal a significant level of discontent among physicians, with many considering scaling back or leaving practice…
More Headlines »
CME Article

Understanding Depression and Cognitive Impairment in the Elderly

Psychiatric Annals, January 2010, Volume 40 Issue 1
Geriatric psychiatrists often receive referrals to determine if an elderly patient is either depressed or demented…
More »
Video
Meeting News

VIDEO: How a physician can perform well in MIPS

March 23, 2017
More »
Advertisement
Advertisement